Dr. David Fidock, assistant professor of microbiology and immunology at the Albert Einstein College of Medicine, is one of just eight scientists nationally to receive a 2003 Investigator in Pathogenesis Disease Award from the Burroughs Wellcome Fund. The grant, which includes $400,000 in funding over the next five years, supports and encourages aggressive, multidisciplinary approaches to investigating pathogenesis (disease development). The recipients of the award are scientists who are working on understanding the interaction between the human host and infectious agents that may be bacterial, viral, fungal, or parasitic in nature.
Dr. Pablo Castillo, assistant professor of neuroscience at the Albert Einstein College of Medicine, has been named a 2003 Pew Scholar in Biomedical Sciences. He is one of just 20 promising biomedical researchers in the nation selected by the Pew Charitable Trusts to receive this prestigious honor.
In a finding that could lead to better methods for preventing tuberculosis, researchers at the Albert Einstein College of Medicine have helped to solve a nearly century-old medical mystery: What caused the bacteria in the TB vaccine to become weakened and therefore safe for human use? Their findings, published in the October 14th issue of the Proceedings of the National Academy of Sciences, could lead to a better vaccine for treating TB, which kills an estimated two million to three million people worldwide each year. Dr. William Jacobs, the study’s senior author, is a Howard Hughes investigator and professor of microbiology and immunology at Einstein.
Dr. Ronald Breslow, Samuel Latham Mitchill Professor of Chemistry and University Professor at Columbia University, will present the 2003 Ira Kukin Chemistry Lecture, “The Chemistry-Biology Interface,” at Yeshiva University on Wednesday, November 12.
On October 16, the Albert Einstein College of Medicine introduced a new free service for the community – The Einstein Health Lecture Series. That first session, focusing on aging and memory, attracted more than 150 community residents.
Researchers at the Albert Einstein College of Medicine and colleagues have discovered that a gene mutation helps people live exceptionally long lives and apparently can be passed from one generation to the next. The scientists, led by Dr. Nir Barzilai, director of the Institute for Aging Research at Einstein, report their findings in the October 15, 2003 issue of the Journal of the American Medical Association (JAMA).
How can faith heal a depleted retirement fund and a depressed soul? After losing his money following the stock market boom of the 1990s, Rabbi Benjamin Blech, professor of Talmud at Yeshiva University (YU), questions the adage that money makes the world go ‘round in his forthcoming book, Taking Stock: A Spiritual Guide to Rising Above Life’s Financial Ups and Downs (American Management Association) to be released October 21.
The Albert Einstein College of Medicine has been awarded a five-year grant from the National Institutes of Health, totaling more than $22 million, to establish an Autoimmunity Center of Excellence (ACE) program.
Mr. Chairman, Mr. Chancellor, Mr. Mayor, Mr. Ambassador, members of the boards, roshei yeshiva, members of the faculty, students, alumni, presidents and delegates of universities, family and friends. I want to thank Michael Jesselson, Dean Efrem Nulman, the Investiture Committee, and so many extraordinary members of the Yeshiva University family for creating this wonderful celebration.
Two noted Talmudic scholars, Rabbi Moshe D. Tendler and Rabbi Aharon Lichtenstein, will deliver the 19th Annual Hausman/Stern Kinus Teshuva lectures. The High Holiday lectures will take place in New York City and Jerusalem.